Phase 2 Study of Temozolomide-Based Chemoradiation Therapy for High-Risk Low-Grade Gliomas: Preliminary Results of Radiation Therapy Oncology Group 0424-Reference-Cited by-同舟云学术

Phase 2 Study of Temozolomide-Based Chemoradiation Therapy for High-Risk Low-Grade Gliomas: Preliminary Results of Radiation Therapy Oncology Group 0424

Published:2015-03 Issue:3 Volume:91 Page:497-504
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Fisher Barbara J.,Hu Chen^ORCID,Macdonald David R.,Lesser Glenn J.,Coons Stephen W.,Brachman David G.,Ryu Samuel,Werner-Wasik Maria,Bahary Jean-Paul,Liu Junfeng,Chakravarti Arnab,Mehta Minesh

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference42 articles.

1. Randomized trial of radiation therapy plus procarbazine, lomustine and vincristine chemotherapy for supratentorial adult low-grade glioma: Initial results of RTOG 9802;Shaw;J Clin Oncol,2012

2. Phase II trial of temozolomide in patients with progressive or recurrent low-grade glioma;Quinn;J Clin Oncol,2003

3. EORTC Study 26972: Second line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, CCNU, vincristine) chemotherapy: EORTC phase II study 26;van den Bent;Ann Oncol,2003

4. Phase II study of protracted daily temozolomide for low-grade gliomas in adults;Kesari;Clin Cancer Res,2009

5. Temozolomide for low-grade gliomas: Predictive impact of 1p/19q loss on response and outcome;Kaloshi;Neurol,2007

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-Grade Glioma Clinical Trials in the United States: A Systematic Review;Life;2024-09-09

2. Racial and social-economic inequalities in systemic chemotherapy use among adult glioblastoma patients following surgery and radiotherapy;Scientific Reports;2024-08-17

3. Chemotherapy in pediatric low-grade gliomas (PLGG);Child's Nervous System;2024-05-31

4. Prognostic values and immune infiltration of KLF15, AQP7, AGPAT9 in glioma and glioblastoma;Future Journal of Pharmaceutical Sciences;2024-03-04

5. Central Nervous System (CNS) Tumors;Tata Memorial Centre Textbook of Oncology;2024